newsfilter
← Latest News
GlobeNewswire·

Skye Bioscience Reports Second Quarter 2025 Financial Results and Business Update

Reiterate top-line data readout from CBeyond™ Phase 2a study of nimacimab planned late Q3/early Q4 2025Patient enrollment in Skye's CBeyondTM Phase 2a obesity trial extension study initiated Independent Data